Abiomed (ABMD) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q4 EPS of $1.16, $0.07 better than the analyst estimate of $1.09. Revenue for the quarter came in at $270 million versus the consensus estimate of $267.67 million.
GUIDANCE:
Abiomed sees FY2023 revenue of $1.14-1.18 billion, versus the consensus of $1.17 billion.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
